Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Kelly Kearney

Kelly Kearney

ID: 1b8338d5-2619-30fb-68c4

/

Unclaimed

/

Organization: Reed Smith LLP

FDA Proposed Rule Establishes Criteria for Difficult Drugs to Compound Under Sections 503A and 503B

Health Industry Washington Watch · April 2, 2024

FDA and DEA seek to ameliorate the shortage and misuse of stimulants

Health Industry Washington Watch · August 4, 2023

OIG approves arrangement involving a testamentary gift to a nonprofit hospital to reduce costs for pediatric patients

Health Industry Washington Watch · February 23, 2022

CMS acknowledges improvement in nursing home COVID-19 response, eliminates certain blanket waivers

Health Industry Washington Watch · April 29, 2021

Open for business in 2021

Health Industry Washington Watch · December 11, 2020

Previous

12 3

Next

Claim This Record

Is this your profile? Upgrade to display your full biography, collected works, social connections, practice areas, and more.

Enhance Your Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog